HomePage
-
Prostate cancer news
-
Jun 30, 2009
:
Benign prostate tissue after surgery ‘not source of biochemical recurrence’
Patients with extremely low-risk prostate cancer after radical prostatectomy and retained benign tissue are highly unlikely to have a measurable prostate-specific antigen or biochemical recurrence, US study findings suggest.
-
Jun 29, 2009
:
ED care suboptimal among many prostate cancer screened men
A significant proportion of individuals screened for prostate cancer who have erectile dysfunction do not have a primary care physician, despite the known links with cardiovascular disease, say US scientists.
-
Jun 29, 2009
:
Laser therapies ‘effective for BPH in small prostate’
Benign prostatic hyperplasia (BPH)s in a small to moderate prostate can be effectively treated with holmium laser ablation or photoselective vaporization, say researchers.
-
Jun 26, 2009
:
Prostate gene expression during brachytherapy may predict outcomes
Biochemical outcomes after brachytherapy for prostate cancer may be predicted by prostate-specific antigen and human kallikrein 2 transcript levels in peripheral blood during treatment, say Israeli scientists.
-
Jun 30, 2009
:
Benign prostate tissue after surgery ‘not source of biochemical recurrence’
-
Features
- AUA 2009 - IMPACT results and more - Congress Reports from Chicago, IL
- EAU 2009 - ProstateLine Congress Reports from Stockholm, Sweden
- ASCO GU 2009 - ProstateLine Congress Reports from Orlando, FL
- ProstateLine Newsletter: To receive an email when new information has been added to ProstateLine, please register
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
